ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,255 | -16.0% | 4,762 | -5.1% | 0.00% | – |
| Q2 2023 | $153,897 | -16.0% | 5,019 | -1.3% | 0.00% | – |
| Q1 2023 | $183,285 | +10.8% | 5,083 | +21.6% | 0.00% | – |
| Q4 2022 | $165,435 | -5.5% | 4,179 | -3.8% | 0.00% | – |
| Q3 2022 | $175,000 | -10.3% | 4,344 | -6.4% | 0.00% | – |
| Q2 2022 | $195,000 | +29.1% | 4,642 | +8.8% | 0.00% | – |
| Q1 2022 | $151,000 | -2.6% | 4,265 | +9.4% | 0.00% | – |
| Q4 2021 | $155,000 | +34.8% | 3,899 | +22.5% | 0.00% | – |
| Q3 2021 | $115,000 | -59.1% | 3,183 | -53.6% | 0.00% | -100.0% |
| Q2 2021 | $281,000 | -56.6% | 6,861 | -53.8% | 0.00% | -50.0% |
| Q1 2021 | $648,000 | -22.6% | 14,866 | -11.1% | 0.00% | 0.0% |
| Q4 2020 | $837,000 | +11.0% | 16,721 | -6.8% | 0.00% | 0.0% |
| Q3 2020 | $754,000 | +216.8% | 17,942 | +267.2% | 0.00% | +100.0% |
| Q2 2020 | $238,000 | – | 4,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |